We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cytotoxic Lymphocytes Fight Stomach Cancer

By LabMedica International staff writers
Posted on 15 Jul 2010
Print article
Cells in the immune system that react to stomach cancer bacterium have been identified.

Helicobacter pylori are Gram-negative, microaerophilic bacteria that can inhabit various areas of the stomach, particularly the antrum. It is one of the most common bacterial infections in the world, and leads to chronic inflammation of the stomach.

These bacteria cause a chronic low-level rubor of the stomach lining, and are strongly linked to the development of duodenal and gastric ulcers and stomach cancer. As the symptoms of stomach carcinomas are varied, they are often discovered at a late stage and have a very poor prognosis. Over 80% of individuals infected with H. pylori are generally symptom-free.

Natural killer (NK) cells, a type of immune cell, can both recognize and kill cells that are infected by viruses and bacteria as well as tumor cells. They kill cells by releasing small cytoplasmic granules of proteins called perforin and granzyme that cause the target cell to die by apoptosis.

A team of scientists at the University of Gothenburg (Gothenburg, Sweden) examined how NK cells reacted to H. pylori. They found that a special type of NK cells was active against the stomach ulcer bacterium and the NK cells produced cytokines, which are the immune system's signal substances and act as a defense against the intruder.

Gastric or stomach cancer is a malignant tumor in the mucous membrane of the stomach, and is one of the more common forms of cancer in Sweden. There are about 24,000 new cases of this disease diagnosed annually in the USA.

Asa Lindgren, Ph.D., who wrote her doctoral thesis on the subject, suggests that NK cells can play an important role in the immune defense against H. pylori. Previously it was shown that a high proportion of NK cells in tumor tissue have contributed to a better prognosis and longer survival for patients with stomach cancer, as these cells help to eliminate the tumor cells.

Related Links:
University of Gothenburg



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.